- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 277/36 - Atomes de soufre
Détention brevets de la classe C07D 277/36
Brevets de cette classe: 263
Historique des publications depuis 10 ans
|
15
|
12
|
24
|
21
|
14
|
17
|
23
|
9
|
13
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Novartis AG | 10338 |
16 |
| Corteva Agriscience LLC | 2648 |
10 |
| ADAMA Makhteshim Ltd. | 551 |
6 |
| Bionevia Pharmaceuticals, Inc. | 12 |
6 |
| The Institute of Cancer Research: Royal Cancer Hospital | 180 |
6 |
| The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 178 |
6 |
| The University of Queensland | 662 |
6 |
| Sumitomo Chemical Company, Limited | 9015 |
5 |
| Ohio University | 356 |
5 |
| University of Southern California | 2123 |
4 |
| The Board of Regents of the University of Texas System | 2282 |
4 |
| Paris Sciences et Lettres - Quartier Latin | 223 |
4 |
| Immunesensor Therapeutics, Inc. | 36 |
4 |
| Merck Sharp & Dohme LLC | 3737 |
4 |
| Orsobio, Inc. | 17 |
4 |
| Syngenta Crop Protection AG | 6577 |
3 |
| Centre National de La Recherche Scientifique | 10914 |
3 |
| The General Hospital Corporation | 4840 |
3 |
| Enanta Pharmaceuticals, Inc. | 433 |
3 |
| Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | 40 |
3 |
| Autres propriétaires | 158 |